Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Position Summary: Reporting to the Director of Corporate Development and Strategy, the Senior Manager of Corporate Development and Strategy will have a direct impact on the strategic evolution of the company. This individual will have a key role in supporting the development and execution of Ardelyx’s short- and long-term growth strategies. This individual will help to identify and assess assets for M&A and licensing, working closely with R&D functional leaders across Non-clinical, Clinical, CMC, and Regulatory. We are looking for a highly motivated and organized professional who is passionate about making a positive impact on our business, our industry, and, ultimately, our patients.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree